We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal appeals court has ruled that Genentech must face a lawsuit filed by cancer treatment centers over its cancer blockbuster Herceptin (trastuzumab). Read More
HHS has expanded an existing partnership between its Biomedical Advanced Research and Development Authority (BARDA) and Emergent BioSolutions, awarding the Maryland company approximately $628 million to manufacture COVID-19 vaccines. Read More
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended eight new drugs for approval at its May meeting, including Johnson and Johnson’s Ebola vaccine. Read More
The FDA issued a draft guidance answering commonly asked questions about the Orange Book, the agency’s reference book for generic drug substitutions, including how it deals with patent listings. Read More
Sixty percent of the public surveyed say they believe a treatment or vaccine for COVID-19 will be developed in just under a year. And once developed, 64 percent said they thought it would be less than a year before the public could begin receiving a COVID-19 treatment or vaccine. Read More
Two watchdog groups are pressing the U.S. Office of Government Ethics to reclassify the “vaccine czar” position President Trump recently filled, making it a government job requiring disclosure of all conflicts of interest instead of a private contractor position not bound by disclosure regulations and criminal ethics laws. Read More